MDM2 and non-cutaneous melanoma: From a cross-check of the DE analysis, we found that the MDM2 proto-oncogene, shown to be recurrently gained in human non-cutaneous melanomas [28], was almost four times more highly expressed in canine oral melanoma tumors than in controls (lFC = 1.96; padj = 0.02).